[Minimally invasive radical prostatectomy: Contribution of robotic support, functional and oncological outcomes].

Abstract:

OBJECTIVES:Radical prostatectomy (RP) remains a standard for localized prostate cancer treatment. The objective of this study is to present this operating technique of the robot-assisted radical prostatectomy (PR-RA) and to evaluate oncological and functional results as well as on the surgical safety. METHODS:A first series of 1679 patients consecutively operated in our institution with this technique from 2005 to 2010 and with a 5-year follow-up evaluated in 2014. The oncology monitoring is ensured with a PSA test every six months during the first three years and once a year the years after if the level remains undetectable. RESULTS:The oncologic outcomes show 17.4% for pT2 stages and 36.9% for pT3 stages positive margins. The level of biological recurrence is 21.27% with an average delay of 88 months as the time needed for the recurrence to occur. At 12 months, urinary continence (0-1pad/day) returned at 94% of all patients and potency with successful penetration for all men is 61.1% and 88.8% for men with sexual activity before surgery. CONCLUSIONS:The technique PRRA seems to be a reliable technique whose functional results studied from meta-analysis seem to be superior in terms of rapidity of recovery of the continence and erection in comparison with classical surgical or laparoscopic approach.

journal_name

Bull Cancer

journal_title

Bulletin du cancer

authors

Hoepffner JL,Gaston R,Mugnier C,Rey D,Lopez L,Roche JB,Riviere J,Piechaud PT

doi

10.1016/j.bulcan.2016.02.006

subject

Has Abstract

pub_date

2016-05-01 00:00:00

pages

461-8

issue

5

eissn

0007-4551

issn

1769-6917

pii

S0007-4551(16)00065-5

journal_volume

103

pub_type

杂志文章
  • [The impact of gynaecological cancers on woman's sexuality and her couple].

    abstract::This article, devoted specifically to gynaecological cancers and their impact on the sexual and marital lives, is a collaboration between the psychologists and onco-gynaecologist within a cancer center. In oncology, gynaecological cancers' treatments involve at the same time anatomical, physiological and functional mo...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2015.02.008

    authors: Vanlerenberghe E,Sedda AL,Ait-Kaci F

    更新日期:2015-05-01 00:00:00

  • [Carcinoembryonic antigen in carcinoma of the uterine cervix (author's transl)].

    abstract::The authors analyse 123 cases of carcinoma of the uterine cervix treated by radiotherapy, with CEA radio-immuno-assay performed before treatment then each time patients are seen in follow-up. The CEA level is positive in 35 per cent of the cases with a mean value of 21 per cent for stage I, 36 per cent for stage II an...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Bolla M,Vrousos C,Horiot JC,Bordes M,Le Dorze C

    更新日期:1979-01-01 00:00:00

  • [Prospective evaluation of pain induced by the transport of patients in the hospital: risk factors and proposal for improvement].

    abstract::Cancer patients are often moved inside the hospital to different examination clinics, such as radiology, CT scan, MRI... and to treatment clinics, such as radiotherapy. These transports induce important pain phenomena, not really recognized by professional teams. As these kinds of pains are expected and can be prevent...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2008.0638

    authors: Nebbak JM,Mathivon D,Di Palma M

    更新日期:2008-05-01 00:00:00

  • [Concrete pain prevention measures regarding hospital internal transport in a cancer center].

    abstract::Iatrogenic pain is a common problem for cancer patients, including those due to hospital internal transport. An original prospective study conducted in 2006 allowed risk factor identification, and from 2007, a pluri-annual progress plan was implemented. Its actions were systematically evaluated and all phases of trans...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2013.1787

    authors: Nebbak JM,Vignozzi A,Bussy C,Charleux D,Laplanche A,Mathivon D,Di Palma M

    更新日期:2013-07-01 00:00:00

  • [Patients' information in percutaneous core breast biopsy].

    abstract::Information takes a large part of patient's perceptions of the procedure. If the information is adapted, patients tolerate the procedure well. We point out indications and explain the different types of procedure. For infraclinical masses, sonographically guided automated core needle biopsy removes samples. Sonographi...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Barreau B,Tastet S,Lakdja F,Henriquès C,Valentin F,Labat MJ,Dilhuydy MH

    更新日期:2005-03-01 00:00:00

  • [Clinical development of anti-angiogenic agents in 2002].

    abstract::In 2002, new developments in anti-angiogenic strategies encompassed two main aspects. Firstly, essential improvements were made in the field of methodology : novel techniques permitted to measure directly on patients the biological effects induced by anti-angiogenic treatments in the course of clinical trials. Secondl...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Bachelot T,Jouanneau E,Blay JY

    更新日期:2003-01-01 00:00:00

  • [Response in patients with melanoma to immunization using melanoma oncolysates of vaccine virus].

    abstract::Thirty-two patients with high risk melanoma (either primary melanoma of the limbs or trunk, or recurrent melanoma) and clinically disease-free following appropriate surgical treatment were immunized with a vaccinia virus oncolysate made from a pool of 4 human melanoma cell lines. Injections were given id weekly for 3 ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Doré JF,Portoukalian J,Berthier-Vergnes O,Jacubovich R,Genève J,Bailly M,Lefthériotis E,Weissbrod A,Mayer M

    更新日期:1990-01-01 00:00:00

  • [Cell cycle regulation after exposure to ionizing radiation].

    abstract::When cells are exposed to ionizing radiation, they initiate a complex response that includes the arrest of cell cycle progression in G1 and G2, apoptosis and DNA repair. DNA is an important subcellular target of ionizing radiation, but oxydative damage to plasma membrane lipids initiates signal transduction pathways t...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Teyssier F,Bay JO,Dionet C,Verrelle P

    更新日期:1999-04-01 00:00:00

  • [The contribution of PET to radiation treatment planning].

    abstract::Advances in medical imaging have greatly enhanced the speciality of radiation oncology by allowing more healthy tissue to be speared for better tumour coverage. Positron emission tomography (PET) with the glucose analogue [18F]-fluoro-2-deoxy-D-glucose (FDG) is a functional imaging method that has become widely used i...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Belkacémi Y,Lartigau E,Kerrou K,Carpentier P,Taïeb S,Giraud P

    更新日期:2007-01-01 00:00:00

  • [Pharmacological consequences of the targeting of epidermal growth factor receptor].

    abstract::Through clearly identified molecular mechanisms, EGFR targeting leads to cell physiology modifications as cell proliferation, apoptosis and DNA repair. These mechanisms can explain the proper activity of EGFR targeting drugs but also represent a strong rational basis on which several experimental studies have been des...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Milano G,Magné N

    更新日期:2003-11-01 00:00:00

  • [Risk of cancer in patients following chronic dialysis and kidney graft].

    abstract:BACKGROUND:A high prevalence of renal insufficiency has been observed in cancer patients as well as a high incidence of de novo cancer in dialysis or renal transplant patients. MATERIAL AND METHODS:We aimed to determine the incidence of cancer in patients under dialysis and in kidney transplant recipients through a se...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2012.1545

    authors: Janus N,Launay-Vacher V,Ferrero JM,Thariat J

    更新日期:2012-03-01 00:00:00

  • [Primary cerebral non-Hodgkin lymphoma in non-immunocompromised subjects].

    abstract::Cerebral non Hodgkin's lymphomas (NHL) of immunocompetent patients are rare disease (1% of all NHL), but their incidence has been steadily increasing in the last 20 years. Most cerebral NHL are diffuse large cell NHL with a B phenotype. These tumors are most often localized in the central nervous system, the eye or me...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,meta分析

    doi:

    authors: Blay JY

    更新日期:1997-10-01 00:00:00

  • [Nice-Saint-Paul de Vence 2020 recommendations for clinical practice: Management of metastatic and/or relapsing endometrial cancer].

    abstract::Endometrial cancer is a common cancer in older women and is often associated with comorbidities. Management of metastatic disease and/or relapse requires a multidisciplinary approach. Recent advances in the understanding of oncogenesis and molecular classification of endometrial cancers offer new therapeutic perspecti...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,实务指引

    doi:10.1016/j.bulcan.2020.06.006

    authors: Alexandre J,Le Frere-Belda MA,Prulhiere K,Treilleux I,Leary A,Pomel C,Chargari C,Ducassou A,Joly F,groupe ARCAGY-GINECO.

    更新日期:2020-10-01 00:00:00

  • Utilisation des inhibiteurs de PD-1 dans les hémopathies lymphoïdes.

    abstract::ANTI-PD-1 ANTIBODIES THERAPEUTIC USE IN LYMPHOID NEOPLASMS: Immune checkpoints blockade is under investigation in oncology, and has demonstrated its clinical efficacy. In hematology, immune checkpoints blockade is in earlier stages of development, but there are strong evidences of PD-1 blockade anti-tumor efficacy in ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/S0007-4551(16)30374-5

    authors: Bounaix L,Bendouda M,Bay JO,Lemal R

    更新日期:2016-11-01 00:00:00

  • [Primary cerebral tumors in children. II: Topography and treatment].

    abstract::In part I of this article, we reviewed the general aspects of childhood brain tumors. In part II, we present the most common neoplasms and their treatment. The quality of the surgical resection appears to be of first importance in the prognosis. Progress in radiotherapy and chemotherapy have contributed to the improve...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Carrie C,Bouffet E,Brunat-Mentigny M,Philip T,Lacroze M

    更新日期:1989-01-01 00:00:00

  • [Uncommon bladder tumours].

    abstract::Bladder tumours are frequent with around 10,000 new cases each year in France. Less than 500 of these cases are not transitional cell carcinoma, the most frequent pathological aspect. The identification of these pathological patterns requires an initial biopsy through transurethral resection. Sarcomatoid, squamous and...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2010.1097

    authors: Boyle H,Fléchon A,Droz JP

    更新日期:2010-01-01 00:00:00

  • [Cytotoxicity of tamoxifen and its principal metabolites in human breast cancer cell lines].

    abstract::The antiestrogen tamoxifen (TAM) has been successfully used to treat breast cancer expressing estrogen and progesterone receptors (ER+ and PR+). However, the development of antiestrogen resistance is frequently observed in patients following long-term treatment. To better understand the mechanism of action of TAM and ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Bachmann-Moisson N,Barberi-Heyob M,Merlin JL,Ledrich ML,Batt AM,Guillemin F

    更新日期:1996-10-01 00:00:00

  • Remaining indications for total mastectomy in breast carcinoma

    abstract::Does radical mastectomy for cancer remain needed? Breast conserving treatment may be achieved by surgery, primary chemotherapy followed by radiotherapy and surgery. This article attempts at defining (according to clinical and pathological parameters of the tumor and patient's characteristics), when conservative treatm...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Weber B,Demange L,Rigaud C,Fernandes-Valoni A

    更新日期:1998-09-01 00:00:00

  • [Better screening for work-related cancers: The experience of Brest University Hospital Occupational Disease Center inpatient service].

    abstract:INTRODUCTION:An in-patient clinical service has been set up in March 2016 in the Occupational Diseases Center of Brest University Hospital, France, to seek for work-relatedness of diseases in patients hospitalized into the oncology and hematology departments. We present here data after two years of existence. METHODS:...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2020.01.013

    authors: Grignoux J,Loddé B,Dewitte JD,Larabi L,Durand-Moreau Q

    更新日期:2020-04-01 00:00:00

  • [Combination of etoposide, cisplatin and ifosfamide (VPH) in the salvage chemotherapy of relapsing or refractory aggressive malignant lymphoma. Study of 51 patients].

    abstract::Fifty-one patients with non-Hodgkin's lymphoma refractory or relapsing after CHOP-like regimen, underwent a salvage chemotherapy by VPH: etoposide 100 mg/m2/d, D1 to D3, cisplatin 20 mg/m2/d, D1 to D5, ifosfamide 1 g/m2/d D1 to D5, mesna 1.2 g/m2/d D1 to D5, every 4 weeks. Among 46 evaluable patients for efficacy, 21 ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Eghbali H,Catry-Thomas I,Soubeyran P,Bonnel C,Hoerni B

    更新日期:1994-09-01 00:00:00

  • [Impact of [18F]-FDG-PET on medical decision making in oncology: evaluation by the referring physicians during the opening year].

    abstract::The first study evaluating directly by the referring physician the clinical impact of [18F]-FDG-PET on modification of patient's management was performed only recently in California by means of a questionnaire. We have used the same methodology to evaluate this clinical impact during the opening year of our PET centre...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Talbot JN,Rain JD,Meignan M,Askienazy S,Grall Y,Bok B,Misset JL

    更新日期:2002-03-01 00:00:00

  • [Epidemiology and anatomy of head and neck cancers].

    abstract::Oral cavity and pharyngeal cancers account for 75% of head and neck cancers and are the fourth most spread cancer in men. Their incidence has decreased since 1980 in men (incidence from 2011 gives 13,930 for lip, oral cavity, pharyngeal and laryngeal carcinomas) but has increased in women, linked to the more recent sm...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2014.1962

    authors: Périé S,Meyers M,Mazzaschi O,De Crouy Chanel O,Baujat B,Lacau St Guily J

    更新日期:2014-05-01 00:00:00

  • [Evaluation of the protocol CMA reinforced in the treatment of endemic Burkitt lymphoma at CHU of Yopougon in Abidjan].

    abstract::We report the results of the protocol CMA (cyclophosphamide, methotrexate, Aracytine) reinforced of 26 patients affected by Burkitt lymphoma in facial-maxillary localisation, in a retrospective study from January 2000 till December 2007 and prospective from January till September 2008. Their average age was 7.89 years...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2010.1037

    authors: Tolo-Diebkilé A,Koffi GK,Nanho CD,Sawadogo D,Kouakou B,Siransi-Bogui L,Ayémou R,Sanogo I

    更新日期:2010-05-01 00:00:00

  • [Individualized anticancer therapies: which regulatory guidelines?].

    abstract::In this review, we will summarize the guidelines on the evaluation of anticancer medicinal products in man and definitions for genomic biomarkers (FDA validated), pharmacogenomics, pharmacogenetics, genomic data and sample coding categories. ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2008.0733

    authors: Bedairia N,Marty M

    更新日期:2008-10-01 00:00:00

  • [Cancer of the prostate: estrogen therapy].

    abstract::From 1941, estrogens are usually used in the treatment of prostatic carcinoma, wrongly in case of adjuvant hormonotherapy and exceedingly because of cardiovascular toxicity from over dosages. A recall of their mechanism of action and toxicity allows to argue about the palliative treatment and to look to their use for ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Mauriac L,Richaud P,Mage P,Thomas L,Lamarche P

    更新日期:1986-01-01 00:00:00

  • [What are the expectations of coordination and accompaniment of French patients with cancer towards their community pharmacist?]

    abstract:PURPOSES:Analyze the relationship and expectations of cancer patients towards the community pharmacist in a pharmaceutical care coordination project. METHODS:In November 2014, a questionnaire was distributed to ambulatory patients of a university hospital specialized in oncology. Thirteen questions explored the consum...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2017.11.017

    authors: Hébert G,Minvielle E,Di Palma M,Lemare F

    更新日期:2018-03-01 00:00:00

  • [Evolution of the hospital pharmacies in public and private hospitals in the cancer network in Lorraine: Oncolor].

    abstract::With the objective of improvement of quality in oncology, an assessment of chemotherapy practice in hospital pharmacies in public and private hospitals was carried out by the regional committee of oncology in Lorraine. The 36 hospitals reporting using chemotherapy, had varied practices. The results of this survey lead...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: May I,Paulus C,Vigneron J,Watelet M,Veyrier B,Bichet F,Bideaux S,Bey P

    更新日期:2001-04-01 00:00:00

  • [Characterization of chromosomal rearrangements by in situ hybridization in glioblastoma].

    abstract::In a case of glioblastoma, the following karyotype was determined: 47, X, - Y, + der(1) t(1;9)(p21;p23), t(1;9)(p21;p23), + 3, + 7, der(9) t(Y;9)(q11;p21), - 13, t(13;16)(p13,p11), del(14)(q11q22). Classical satellite DNAs are mainly located in chromosomes 1, 9, 15, 16 and Y. Because, most of these chromosomes were im...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Bourgeois CA,Kokalj-Vokac N,Dutrillaux AM,Poisson M,Delattre JY,Vega F,Malfoy B,Dutrillaux B

    更新日期:1994-05-01 00:00:00

  • [Methodological and ethical quality in phase III cancer trials: role of the cooperative group].

    abstract::Phase III clinical trials (CT) are carried out more and more often in a multicentric way, under the aegis of one or more cooperative groups (CG). The goal of this study was to analyze the influence of the GC on ethical quality (EQ) and methodological quality (MQ) in phase III cancer CT. EQ (Berdeu-score) and MQ (Jadad...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Tuech JJ,Pessaux P,Moutel G,Thoma V,Schraub S,Hervé C

    更新日期:2004-10-01 00:00:00

  • [Use of maintenance therapy and complete discontinuation for therapeutic management of non-resectable metastatic colorectal cancer].

    abstract::Management of unresectable metastatic colorectal cancer dramatically changed over the past 20 years. News standards of care combine cytotoxic drugs like fluoropyrimidines, irinotecan and oxaliplatin, with targeted therapies such as anti-EGFR monoclonal antibodies and anti-angiogenic agents. Survival benefit results fr...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2014.1984

    authors: Senellart H,Hiret S,Guerin-Meyer V,Bennouna J

    更新日期:2014-06-01 00:00:00